Athrombopenic purpura (eng. purpura athrombopenica) is a rare disease that is characterized by a low level of platelets in the blood. Platelets are blood cells that play an important role in the blood clotting process, preventing bleeding and allowing wounds to heal.
With athrombopenic purpura, the level of platelets in the blood decreases, which leads to disruption of the blood clotting process. This can manifest itself in the form of bleeding gums, nose, hemorrhages in the skin, mucous membranes, and internal bleeding. Patients may also experience skin bruising, spots, and rashes.
The causes of athrombopenic purpura are not fully understood. However, it is known that the disease may be associated with dysfunction of the immune system and the production of antibodies that are directed against one's own platelets. The disease occurs more often in women than in men.
To diagnose athrombopenic purpura, a blood test to measure platelet levels is performed, and other testing methods, such as a bone marrow biopsy or immunological tests, may also be used.
Treatment of athrombopenic purpura depends on the severity of the disease. In some cases, the patient may need to be hospitalized. Treatment may include medications to increase platelet levels, as well as immunosuppressive therapy to reduce the activity of the immune system.
Athrombopenic purpura is a serious condition that, if left untreated, can lead to complications such as bleeding and an increased risk of infection. Therefore, it is important to consult a doctor when symptoms of the disease appear in order to receive timely diagnosis and treatment.